INVIVO THERAPEUTICS HLDGS CO (NVIVQ)
Institutional ownership reported to the SEC as of Q1 2024, across 9 quarters.
2
Reporting holders
$5.2K
Reported value
0.0%
Held as options
-12
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | $5.2K | 23,741 | 0.00% | new | NEW |
| VIMA LLC | $2 | 2 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 2 | $5.2K | 23,743 | 1 | 0 | 0 | 0.0% |
| Q4 2023 | 14 | $68.3K | 93,603 | 0 | 4 | 2 | 0.0% |
| Q3 2023 | 14 | $102.5K | 90,331 | 2 | 5 | 1 | 0.0% |
| Q2 2023 | 14 | $108.0K | 79,904 | 1 | 2 | 2 | 0.0% |
| Q1 2023 | 16 | $95.7K | 90,262 | 7 | 1 | 2 | 0.0% |
| Q4 2022 | 11 | $656.7K | 279,447 | 4 | 1 | 1 | 0.0% |
| Q3 2022 | 10 | $703.0K | 164,088 | 5 | 4 | 0 | 0.0% |
| Q2 2022 | 5 | $256.0K | 62,924 | 5 | 0 | 0 | 0.0% |
| Q1 2022 | 1 | $1.0K | 1 | 1 | 0 | 0 | 0.0% |